IGF1 and cancer: A recently published study reported that periodic fasting or a fasting-mimicking diet can enhance the anti-cancer activity of anti-estrogen therapies by lowering the circulating levels IGF-1, insulin and leptin and consequently inhibiting the AKT mTOR pathway (Caffa et al., 2020).